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S T U DY BRI E F

Modern contraceptive use in
India has steadily increased,
but remains heavily skewed
towards female sterilization.
Use of modern spacing methods
such as injectables, the pill,
and the IUCD is low, and
discontinuation rates are high.
Achieving the goal of expanding
the method mix by increasing
reliance on modern spacing
methods, as laid out in India’s
FP2020 commitment, requires
understanding and addressing
the reasons for discontinuation
and for method switching (or
non-switching), from both
the user’s and the provider’s
perspective.

The use of modern contraceptive methods has steadily increased in
India from 33% in 1992-93 (NFHS-1) to 48% in 2007-08 (DLHS-3). The
method mix favors female sterilization, with close to 3 out of 4 (72%)
married modern contraceptive users choosing female sterilization,
followed by condoms (13%), pills (9%), IUCD (4%), and male sterilization
(2%) (DLHS-3). As articulated in its FP2020 commitment, India is looking
to expand its method mix to include a greater reliance on modern
spacing methods and postpartum IUCDs. Discontinuation rates, however,
remain high for modern spacing methods. The one-year contraceptive
discontinuation rate for modern spacing methods is 42.3% (NFHS-3).
Discontinuation rates are the highest for injectables (53.4%), followed
by the pill (49.2%), condoms (44.8%) and the IUCD (19.8%). In only 1
out of 10 (9.8%) discontinuation episodes did the family planning (FP)
user switch to a different contraceptive method. In order to realize a
goal of 48 million additional residents adopting FP by 2020 through
an expanded contraceptive method mix, a better understanding
of contraceptive use dynamics like factors that influence decisionmaking around contraceptive choice, discontinuation, and switching is
paramount to designing effective family planning programs that meet the
needs of women and their families.

STUDY OBJECTIVES
The Evidence Project, in response to a request from USAID/India
to explore contraceptive use dynamics among married women in
India, proposes to conduct a cohort study with the following research
objectives:
1. to assess one-year modern spacing contraceptive discontinuation
rates by modern spacing methods (pill, IUCD/PPIUD, injectable)
among a cohort of modern spacing contraceptive users
2. to measure influencing facilitators for contraceptive continuation
and discontinuation, including intensity of experienced side effects
3. to measure the Method Information Index (MII) that measures
client’s recall of counseling information received
4. to assess influencing factors that lead to contraceptive switching or
non-switching
5. to explore providers’ attitudes about contraceptive discontinuation
and switching, and their practices with clients who want to
discontinue or switch
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METHODOLOGY
A cohort study of approximately 3,000 new spacing modern
method users (pill, IUCD/postpartum IUD, and injectables)
will be followed for one year. New users will be married,
between the ages of 15-49 years old, and may or may not
have used contraceptives previously. They will be interviewed
at the time of method adoption and at three follow-up points:
3 months, 6 months, and 1 year.
The study will take place in three diverse states that will be
selected in consultation with USAID/India and the Ministry
of Health and Family Welfare (MOHFW). The study states will
be selected from the states where Jhpiego, under the MCSP
Project, is providing technical assistance to the MOHFW
to expand the availability of contraceptives and improve
the quality of services offered at select government health
facilities. Those states include: Andhra Pradesh, Assam,
Chhattisgarh, Maharashtra, and Orissa. Within each of the
selected three states, recruitment of new IUCD/PPIUD and
injectable users will occur at government health facilities
that are receiving support from Jhpiego and that are not
receiving support from Jhpiego. New pill user recruitment will
take place through community health workers (ASHAs).

DATA TO BE COLLECTED
An intensity of side effects scale will be developed and
tested to further our understanding of how side effects
impact different spheres of women’s lives (e.g. domestic,
religious, sexual, social), and to determine at what point
a side effect becomes intolerable, such that a woman
chooses to discontinue its use. Likert-style questions will be
developed to assess women’s experiences of side effects,
and women will be asked to rate the intensity of side effects
on a scale of 1 to 10. These measures will be assessed over
time at the individual level, and used to predict subsequent
contraceptive use and discontinuation.
Data will also be collected on the Method Information
Index, an index collected nationally by FP2020 and the DHS
that measures the extent to which women were told about
alternative methods and were given sufficient information
about the alternative methods. The Index is based on three
questions: 1) Were you told about family planning methods
other than the one you selected today?; 2) Were you told
today about side effects or problems you might have with the

selected method?; and 3) Were you told today what to do if
you experience side effects?
Given the CPR and TFR trends reported recently in the
NFHS-4 in several states, data will be collected to explore
knowledge, attitudes and use of emergency contraceptive
pills (ECP) since the last birth interval. These data will be
collected in the enrollment and follow-up surveys to assess
changes in ECP awareness and use over time.
In addition, in-depth interviews will be conducted with a
subsample of respondents who discontinue use of a modern
spacing method and a subsample who switch to a different
method during the one-year follow-up period, to further
understand the social and contextual issues that lead to
these behaviors.
On the supply side, surveys will be conducted with providers
to assess their knowledge of medical practices related
to safe procedures of starting a new FP method while
discontinuing a different FP method, attitudes towards
clients who seek counseling related to side effects and who
may wish to discontinue a method, and provider practices
when clients seek to discontinue a method, including
whether providers counsel clients on method switching and
if so, switching to which method and why. Facility audits
will also be conducted at each facility where respondents
are recruited to ascertain the availability of contraceptive
methods, as this influences a user’s ability to switch
methods.

RESEARCH UTILIZATION
The study will be supported by a strong research utilization
(RU) strategy that begins with the designation of study
advisory committee (SAC) members who will meet
biannually. Members of the SAC will include Ministry
of Health and Family Welfare, donors like USAID, The
David & Lucile Packard Foundation, DFID and The Bill &
Melinda Gates Foundation, in addition to technical and
implementing partners in India, including Jhpiego, IPPF,
EngenderHealth and MSI. The SAC will meet to review the
study design, discuss preliminary findings, and participate in
interpretation of study findings. With the SAC, programmatic
recommendations will be determined and briefs, in addition
to other materials, will be developed for widespread
dissemination.
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